NOS1AP is a novel molecular target and critical factor in TDP-43 pathology (2022)
Attributed to:
The impact of TDP-43 on translation and the response to axonal damage in amyotrophic lateral sclerosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/braincomms/fcac242
PubMed Identifier: 36267332
Publication URI: http://europepmc.org/abstract/MED/36267332
Type: Journal Article/Review
Parent Publication: Brain Communications
Issue: 5
ISSN: 2632-1297